CDEK
← All organizations

DUSA Pharmaceuticals

For profitContributed to NME

Also known as: DUSA | DUSA Pharmaceuticals, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Mar 1, 2007

First marketed drug

Dec 7, 1999

First NDA

Dec 7, 1999

Last known activity

Oct 20, 2017

Acquired by Sun Pharmaceuticals on Jan 1, 2012

Timeline

1990s

  1. Jan 1, 1991

    DUSA Pharmaceuticals— Founded

  2. Dec 7, 1999

    aminolevulinic acid— NDA Organization

2000s

  1. Jan 1, 2006

    Sirius Laboratories— Acquired

2010s

  1. Jan 1, 2012

    Sun PharmaceuticalsSun Pharmaceuticals— Acquired By

Drugs by trial phase (3 distinct, 19 trials)

Phase 4 (1 own, 0 via acquisition)

Other trials (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (27)

Details

Founded
Wilmington, MA, US Jan 1, 1991
First NDA
Dec 7, 1999
Last known activity
Oct 20, 2017